Literature DB >> 34372785

Prevalence and factors associated with trichomonas vaginalis infection among female sex workers in Togo, 2017.

Martin Kouame Tchankoni1, Alexandra Marie Bitty-Anderson2, Arnold Junior Sadio1,3, Fifonsi Adjidossi Gbeasor-Komlanvi1,3, Valentine Marie Ferré4,5, Wendpouiré Ida Carine Zida-Compaore1, Ameyo Monique Dorkenoo6, Bayaki Saka7, Anoumou Claver Dagnra8, Charlotte Charpentier4,5, Didier Koumavi Ekouevi9,10,11,12.   

Abstract

BACKGROUND: The aim of this study was to estimate the prevalence and factors associated with Trichomonas vaginalis (T. vaginalis) among female sex workers (FSW) in Togo in 2017. A cross-sectional bio-behavioral study was conducted from August to October 2017 using a respondent-driven sampling method in four cities in Togo.
METHOD: A standardized questionnaire was used to record socio-demographic data and sexual behavior patterns. T. vaginalis detection by molecular biology tests was performed using Allplex STI Essential Assay which detect also 6 others micro-organisms. A blood sample was drawn and serological test using SD Bioline Duo VIH/Syphilis rapid test was performed for Human immunodeficiency virus (HIV) and syphilis testing.
RESULTS: A total of 310 FSW with median age 25 years, interquartile range (IQR) [21-32 years] were included. The prevalence of T. vaginalis was 6.5% (95%CI = [4.1-9.9]) and, overall, prevalence of other STI ranged from 4.2% (95%CI = [2.3-7.2]) for N. gonorrhoeae to 10.6% (95% CI = [7.5-14.7]) for HIV. Binary logistic regression was conducted to assess factors associated with T. vaginalis infection. Living in Lomé (aOR = 3.19; 95%CI = [1.11-11.49]), having had sexual intercourse before the age of 18 (aOR = 5.72; 95%CI = [1.13-10.89]), and being infected with C. trachomatis (aOR = 3.74; 95%CI = [2.95-12.25]) were factors associated with T. vaginalis among FSW.
CONCLUSION: The prevalence of T. vaginalis infection using molecular test was low among FSW in Togo. Extensive studies are needed to confirm and to better understand the epidemiology of T. vaginalis among this population and in other populations in Togo.
© 2021. The Author(s).

Entities:  

Keywords:  Female sex workers; HIV; Trichomonas vaginalis; West Africa

Year:  2021        PMID: 34372785     DOI: 10.1186/s12879-021-06432-w

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  21 in total

1.  Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial.

Authors:  Jane R Schwebke; Marcia M Hobbs; Stephanie N Taylor; Arlene C Sena; Michael G Catania; Barbara S Weinbaum; Ann D Johnson; Damon K Getman; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

2.  Trichomonas vaginalis: investigation of a novel diagnostic method in urine samples using cysteine proteinase 4 gene and PCR technique.

Authors:  Mansoureh Vatanshenassan; Sassan Rezaie; Mehdi Mohebali; Nasrin Niromand; Bahram Kazemi; Zahra Babaei; Mostafa Rezaeian
Journal:  Exp Parasitol       Date:  2010-04-29       Impact factor: 2.011

3.  Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.

Authors:  Prashini Moodley; David Wilkinson; Cathy Connolly; Jack Moodley; A Willem Sturm
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

Review 4.  Trichomoniasis--an important cofactor of human immunodeficiency virus infection.

Authors:  Agnieszka Beata Serwin; Marta Koper
Journal:  Przegl Epidemiol       Date:  2013

Review 5.  Global epidemiology of Trichomonas vaginalis.

Authors:  Danielle N Poole; R Scott McClelland
Journal:  Sex Transm Infect       Date:  2013-06-06       Impact factor: 3.519

6.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

Authors:  R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten
Journal:  J Infect Dis       Date:  2007-01-22       Impact factor: 5.226

Review 7.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting.

Authors:  Lori Newman; Jane Rowley; Stephen Vander Hoorn; Nalinka Saman Wijesooriya; Magnus Unemo; Nicola Low; Gretchen Stevens; Sami Gottlieb; James Kiarie; Marleen Temmerman
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

8.  Prevalence of Trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional study.

Authors:  Dewi J de Waaij; Jan Henk Dubbink; Sander Ouburg; Remco P H Peters; Servaas A Morré
Journal:  BMJ Open       Date:  2017-10-08       Impact factor: 2.692

9.  Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis.

Authors:  Simon Chengo Masha; Piet Cools; Eduard J Sanders; Mario Vaneechoutte; Tania Crucitti
Journal:  Sex Transm Infect       Date:  2018-10-19       Impact factor: 3.519

10.  Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016.

Authors:  Jane Rowley; Stephen Vander Hoorn; Eline Korenromp; Nicola Low; Magnus Unemo; Laith J Abu-Raddad; R Matthew Chico; Alex Smolak; Lori Newman; Sami Gottlieb; Soe Soe Thwin; Nathalie Broutet; Melanie M Taylor
Journal:  Bull World Health Organ       Date:  2019-06-06       Impact factor: 9.408

View more
  1 in total

1.  High burden of self-reported sexually transmitted infections among female sex workers in Togo in 2021.

Authors:  Alexandra M Bitty-Anderson; Fifonsi A Gbeasor-Komlanvi; Akila W Bakoubayi; Martin K Tchankoni; Arnold J Sadio; Mounerou Salou; Claver A Dagnra; Didier K Ekouevi; Patrick A Coffie
Journal:  Front Public Health       Date:  2022-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.